RNAC Secures up to $150M Non-Dilutive Financing, Extends Cash Runway into 2028, Anticipates Multiple Clinical Catalysts in 2027
Cartesian Therapeutics, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $7.54
-6.2% in 1h after detection
Post-detection moves
1h
-6.2%
1d
-4.4%
3d
+4.0%
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS